Chemical modification of therapeutic drugs or drug vector systems to achieve targeted therapy: looking for the grail.
about
Composite glycidyl methacrylated dextran (Dex-GMA)/gelatin nanoparticles for localized protein delivery.Synthesis of oligo(ethylene glycol) substituted phosphatidylcholines: secretory PLA2-targeted precursors of NSAID prodrugsPreclinical investigation of tolerance and antitumour activity of new fluorodeoxyglucose-coupled chlorambucil alkylating agents.Bacterial Magnetosome: A Novel Biogenetic Magnetic Targeted Drug Carrier with Potential Multifunctions.Comparison of two kinds of nanomedicine for targeted gene therapy: premodified or postmodified gene delivery systems.[Gd@C(82)(OH)(22)](n) nanoparticles inhibit the migration and adhesion of glioblastoma cells.Cathepsin B-cleavable doxorubicin prodrugs for targeted cancer therapy (Review)Nanovehicular intracellular delivery systems.Treatment of Parkinson's disease with trophic factors.Emerging technologies in the delivery of erythropoietin for therapeutics.CNS drug targeting: have we travelled in right path?Strategies for drug delivery to the central nervous system by systemic route.2-Oxabutane as a substitute for internal monomer units of oligosaccharides to create lectin ligands.Bioactive clusters promoting cell penetration and nucleic acid complexation for drug and gene delivery applications: from designed to self-assembled and responsive systems.Quaternary ammonium-melphalan conjugate for anticancer therapy of chondrosarcoma: in vitro and in vivo preclinical studies.Biocompatibility of bacterial magnetosomes: acute toxicity, immunotoxicity and cytotoxicity.
P2860
Q33420319-5B63DD94-DF1B-45E9-ACFC-C3B2C728C8B3Q34081569-21F09AD4-CDE0-45E1-BF8A-9AD36D8F82C0Q34615208-C62CD229-8C91-4448-81F3-BCC49875D158Q35846813-5721B060-655F-4AF9-B45D-2457775F0587Q35972662-2F8E5818-683A-4936-98E7-A2D8A4AFE463Q36216810-CD242203-E62F-4665-B673-6F896CE9A168Q36643541-8BEDC031-62ED-44C2-9ED4-9316C93C876AQ37058812-B10D6A4A-EED0-4811-8E02-EF07FEB92745Q37131259-B844D2AB-F3D7-47A2-8F4A-335FCE28C88DQ37646523-DB365654-250E-4657-937F-530A9118EC6DQ38127262-3A3DEB95-79F4-4215-8D4D-91592EA993D7Q38182668-B1BE49F6-EA1B-4129-9EB3-06E318B41976Q38332627-9E51EB36-EF5F-4EF9-9F31-9265F802374FQ38722141-83F605E2-646F-42C9-9F28-FB3F2F46A947Q39557265-2EC43DDA-0AD3-4DF0-9056-7621AF10975AQ39663121-69892B1F-208E-4B09-B807-BC826E5361F8
P2860
Chemical modification of therapeutic drugs or drug vector systems to achieve targeted therapy: looking for the grail.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Chemical modification of thera ...... herapy: looking for the grail.
@ast
Chemical modification of thera ...... herapy: looking for the grail.
@en
type
label
Chemical modification of thera ...... herapy: looking for the grail.
@ast
Chemical modification of thera ...... herapy: looking for the grail.
@en
prefLabel
Chemical modification of thera ...... herapy: looking for the grail.
@ast
Chemical modification of thera ...... herapy: looking for the grail.
@en
P2860
P356
P1476
Chemical modification of thera ...... herapy: looking for the grail.
@en
P2093
Juillerat-Jeanneret L
P2860
P304
P356
10.1002/MED.20086
P577
2007-07-01T00:00:00Z